% | $
Quotes you view appear here for quick access.

Vertex Pharmaceuticals Incorporated Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • verityvoila verityvoila Nov 13, 2012 1:41 PM Flag

    Vertex hepatitis C situation is unchanged but its cystic fibrosis drugs will be blockbusters

    While I'd love to see the combo to market by 2014, I think it will be 2015 for these reasons: I think FDA will insist on a 1 year trial (we'll know soon, and if only 6 months required, that will make it quicker). Even if they start in early 2013, it could easily be mid-year before fully enrolled and that is with a fast enrollment which I think is a certainty given EVERYONE wants this combo NOW. Which would mean that it would be, at earliest, mid-2014 before everyone has finished 1 year and then you need some time to evaluate and put together application and then if approved on fast track at least 3 more months. We're in the "if we can only keep DS healthy for another 2 years," coping strategy, which I guess would be end of 2014, but now that I think about it, it is more likely 2.5 years. What might change this: 1) 6 month trial; or 2) steller results after 6 months and FDA allows approval to go forward while still in Phase 3 (1 year period). But it could be early 2015. I know Vertex wants/ needs this to market soon, so it will be doing everything possible to get it there.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Vertex aims to file the NDA to the FDA by the end of Q4-2014 or Q1-2015. With this timelines in mind, add 4-6 months for approval and VX-809 will not be in the market until mid 2015 the soonest, sometime between June-September 2015. Expect that revenues will not be significant until 2016 with few months needed to launch and ramp up sales.

81.90-6.30(-7.14%)Jun 24 4:00 PMEDT